- $2.42bn
- $2.56bn
- $466.15m
- 75
- 62
- 87
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 141 | 195 | 211 | 249 | 354 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 137 | 189 | 208 | 242 | 336 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 72.5 | 108 | 144 | 178 | 257 |
Provision for Income Taxes | |||||
Net Income After Taxes | 51.3 | 80.6 | 110 | 130 | 192 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 51.6 | 80.1 | 111 | 130 | 192 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 51.6 | 80.1 | 111 | 130 | 192 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.07 | 1.45 | 1.97 | 2.36 | 3.56 |